haloperidol
Generic: haloperidol
Labeler: innogenix, inc.Drug Facts
Product Profile
Brand Name
haloperidol
Generic Name
haloperidol
Labeler
innogenix, inc.
Dosage Form
TABLET
Routes
Active Ingredients
haloperidol 2 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71247-152
Product ID
71247-152_ef4d587e-1e3e-4dbd-82f8-b102ec30df12
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA071173
Listing Expiration
2027-12-31
Marketing Start
2021-02-18
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71247152
Hyphenated Format
71247-152
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
haloperidol (source: ndc)
Generic Name
haloperidol (source: ndc)
Application Number
ANDA071173 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (71247-152-01)
- 1000 TABLET in 1 BOTTLE (71247-152-10)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ef4d587e-1e3e-4dbd-82f8-b102ec30df12", "openfda": {"nui": ["N0000180182"], "unii": ["J6292F8L3D"], "rxcui": ["197754", "310670", "310671", "310672", "314034", "314035"], "spl_set_id": ["2c26af24-5ed3-4eb7-8d29-d6a019320a70"], "pharm_class_epc": ["Typical Antipsychotic [EPC]"], "manufacturer_name": ["Innogenix, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (71247-152-01)", "package_ndc": "71247-152-01", "marketing_start_date": "20210218"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (71247-152-10)", "package_ndc": "71247-152-10", "marketing_start_date": "20210218"}], "brand_name": "Haloperidol", "product_id": "71247-152_ef4d587e-1e3e-4dbd-82f8-b102ec30df12", "dosage_form": "TABLET", "pharm_class": ["Typical Antipsychotic [EPC]"], "product_ndc": "71247-152", "generic_name": "Haloperidol", "labeler_name": "Innogenix, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Haloperidol", "active_ingredients": [{"name": "HALOPERIDOL", "strength": "2 mg/1"}], "application_number": "ANDA071173", "marketing_category": "ANDA", "marketing_start_date": "20210218", "listing_expiration_date": "20271231"}